address1,address2,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,marketState,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,isEarningsDateEstimate,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,regularMarketChangePercent,regularMarketPrice,shortName,longName,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,trailingPegRatio
Biotech Center,Arvid Wallgrens Backe 20,Gothenburg,413 46,Sweden,46 0 31 13 73 31,https://isofolmedical.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.",5,"[{'maxAge': 1, 'name': 'Mr. Petter Segelman Lindqvist', 'title': 'Chief Executive Officer', 'fiscalYear': 2024, 'totalPay': 2767000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Roger  Tell M.D., Ph.D.', 'age': 59, 'title': 'Chief Medical Officer', 'yearBorn': 1965, 'fiscalYear': 2024, 'totalPay': 67000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Margareta  Hagman M.B.A.', 'age': 58, 'title': 'Chief Financial Officer', 'yearBorn': 1966, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,4,0.906,0.9595,0.87,0.969,0.906,0.9595,0.87,0.969,0.0,1.319,-17.24,4258276,4258276,859830,1118484,1118484,0.865,0.87,0,0,166524608,0.8425,4.885,1.2195175,2.0874443,0.0,0.0,SEK,False,69716512,0.0,128910318,183802000,0.18581,0.06058,193184000,0.398,2.1658292,1735603200,1767139200,1743379200,-48663000,-0.26,-0.05,-1.383,-0.318038,0.11708844,EQUITY,0.862,1.7,1.7,1.7,1.7,0.0,strong_buy,1,82108000,0.508,-50424248,0,4.26,4.313,-0.29111,-0.54912,-39997000,-29213500,-45104000,0.0,0.0,0.0,SEK,ISOFOL.ST,en-US,US,Equity,Delayed Quote,True,HIGH,PREPRE,False,1491289200000,-0.04400003,0.87 - 0.969,Stockholm,859830,0.019500017,0.023145422,0.8425 - 4.885,-4.0230002,-0.82354146,-31.803799,1752836340,1752836340,1752836340,False,[],1751902184,STO,finmb_47549518,Europe/Stockholm,CEST,7200000,se_market,False,15,0,0.0 - Strong Buy,False,-4.8565154,0.862,Isofol Medical AB,Isofol Medical AB (publ),-0.26,-0.05,-0.2,-4.31,-0.35751748,-0.29316306,-1.2254443,-0.58705485,
